Clear Trail Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Clear Trail Advisors's ABBV Position: Q3 2026 in Review
Clear Trail Advisors increased its AbbVie (ABBV) stake by 24% in Q3 2026, buying an estimated $734K and bringing the position to 14,766 shares worth $3.86M. The position accounts for 0.59% of the portfolio, ranked #49.
Clear Trail Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,276 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Clear Trail Advisors held 14,766 shares of AbbVie worth $3.86M as of Q3 2026.
- Clear Trail Advisors bought 2,862 AbbVie shares in Q3 2026, an estimated $734K.
- AbbVie made up 0.59% of Clear Trail Advisors's portfolio in Q3 2026, its #49 holding.
- Clear Trail Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 4,276 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Clear Trail Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.